CACPT Newsletter

CACPT Newsletter
SPRING 2016
WHAT’S INSIDE?
Canadian Respiratory Conference
Canadian Cardiovascular Congress
New Bylaws
Save Lives: Clean Your Hands
Continuing Education
World COPD Day
CACPT Continuing Professional
Program
Articles
PFT Symposium 2015 recap
PFT Symposium 2016
Canadian Respiratory Conference 2016
April 14-16, 2016 – Halifax, Nova Scotia
http://crc.lung.ca/
The Canadian Respiratory Conference (CRC)
is the premier national educational and scientific meeting for the respiratory community in Canada. The annual conference
offers a broad scientific program developed
by clinicians, multidisciplinary healthcare
professionals, scientists and educators in
our community who have developed an
excellent reputation in the field of respiratory medicine, locally and internationally.
The program promotes discussion of the
most significant developments in respiratory health.
The CRC is a joint initiative of the Canadian Thoracic Society, the Canadian
Respiratory Health Professionals, and the Canadian Lung Association.
2016 Canadian Cardiovascular Congress
October 22-25, 2016 – Montreal, Quebec
http://www.cardiocongress.org/
Year after year, CCC continues to grow by bringing returning and new delegates to different locations across the country. The importance of the CCC is
always expressed by attendees after the event: It’s the most essential networking event of the year and the best opportunity to stay up-to-date on
the latest Canadian research, policy and practice in the field, making it one
of Canada’s longest running medical meetings for a reason.
facebook.com/cacpt.ca
New Bylaws
Please be aware that the new CACPT Bylaws is accessible online and will require a username and password. Please contact
one of our board members for details.
SAVE LIVES: Clean Your Hands 5 May 2016
Safe Surgical Care SAVES LIVES: Clean Your Hands – Prioritizing improvement of hand
hygiene practices in all surgical services
The problem
Preventing infections and reducing an avoidable burden on health systems is still critical around the world today and is
part of making sure every health-care setting is safe for treating every single patient. Surgical patients are at risk of health
care-associated infections (HAI), in particular surgical site infections (SSI) and device-associated infections (e.g. catheterassociated urinary tract infection). SSIs are a burden on every health-care facility as featured in this WHO report from
2011.
How the SAVE LIVES: Clean Your Hands campaign will support
a solution
Improving hand hygiene practices in all surgical services through the continuum of care, from surgical wards to operating theatres, to outpatient surgical
services, is the primary focus of this year’s 5 May campaign. Useful products
available from WHO this year will include:
 a 5 May 2016 slogan, image and hashtag to let everyone join in spreading consistent messages around the world;
 a new infographic image featuring messages on surgical site infections
and their prevention;
 some educational posters focused on hand hygiene in relation to surgical interventions/care ;
 exciting information on how everyone can join together in an activity on
or around 5 May that will continue to raise the global profile of hand
hygiene in health care - to be announced soon!
 a report on the 2015 WHO global Hand Hygiene Self-Assessment Framework survey - to be released on 5 May;
 a report on a global consumer survey on HAI and hand hygiene – on 5
May;
 the SAVE LIVES: Clean Your Hands newsletter, aimed at keeping everyone updated on these useful resources as they are issued by WHO.
An on-going focus on hand hygiene improvement in all areas
Hand hygiene in health care at the right time saves lives. The WHO Hand Hygiene Improvement Toolkit is available to support anyone, in any setting, to participate in this global movement.
Considering the priority of hand hygiene improvement in a broader context, 5 May 2016 also aims to support the water,
sanitation and hygiene (WASH) agenda, given that 35% of health-care facilities still do not have soap and water for hand
hygiene, among other things. Find out more: http://www.who.int/gpsc/5may/EN_PSP_GPSC1_5May_2016/en/
Continuing Education
CCCEP: The Education, COPD and Asthma courses have been accredited by Canadian Council on Continuing Education in
Pharmacy. Pharmacists have been involved in development of the curricula and review of the content.
The Canadian Council on Continuing Education in Pharmacy has confirmed accreditation as follows:



Education for Chronic Disease Management Course - 27.50 CEUs
COPD Management Course - 18.00 CEUs
Asthma Management Course - 17.50 CEUs
For more information, please visit: https://resptrec.org/
World COPD Day
World COPD Day is organized by the Global Initiative for Chronic Obstructive
Lung Disease (GOLD) in collaboration with health care professionals and
COPD patient groups throughout the world. Its aim is to raise awareness
about chronic obstructive pulmonary disease (COPD) and improve COPD care
throughout the world
Each year GOLD chooses a theme and coordinates preparation and distribution of World COPD Day materials and resources. World COPD Day activities are organized in each country by health care
professionals, educators, and members of the public who want to help reduce the burden of COPD.
The first World COPD Day was held in 2002. Each year organizers in more than 50 countries worldwide have carried out
activities, making the day one of the world's most important COPD awareness and education events.
http://www.goldcopd.org/wcd-about.html
http://www.aerihealth.me/
Education Committee
Pulmonary Committee:
Medical Advisors:
Pulmonary Head:
David Hu
Pulmonary:
Dr. Larry Lands
Dr. Meredith Chiasson
Committee Members:
Bernie Ho
Jennifer Hyde
Bonnie Steadman
Joyce Wu
Cardiac:
Dr. Neil Pearce
Dr. Robert Teskey
Looking for enthusiastic
member from Pacific
coast to join our Board of
Directors!
Cardiac Committee:
Cardiac Head:
Elain Krieger
National Registry Examination
Registry exam: June 4, 2016
Committee Members:
Jeff Hamm
Campbell Scherger
CACPT Continuing Professionalism* Program
Please be aware that the new CACPT Continuing Professionalism Program is accessible online and will require a username
and password. Please contact one of our board members for details.
Continuing Education: 1 hour = 1 credit
Example: webinar, journal article, lecture.
Workplace Activity: 1 hour = 1 credit
Example: lunch & learn, grand rounds, staff workshop.
Volunteering/CACPT business: 4 hours = 2 credits
Example: CACPT committee or meetings, Lung Association, Heart and Stroke Foundation.
Preceptorship: 4 hours = 2 credits
Example: CACPT students, medical students, demonstrations, teaching.
Advanced Continuing Education: each full day = 4 credits or 1 credit per lecture
Example: Spirotrec, COPD education, Advanced Cardiac Life Support, conference.
*Professionalism: the skill, good judgment, and polite behavior that is expected from a person who is trained to do a job well.
Articles
Suboptimal Care for Women With CAD Linked to Higher Long-Term Mortality
By Caitlin E. Cox
Friday, February 26, 2016
Data from a US registry hint that there may well be ways to at least partially erase the sex disparity between women and men hospitalized for cardiac conditions. After they leave the hospital, women face higher 3-year mortality, but more than two-thirds of that difference seems to stem from “suboptimal care” at the time of discharge, researchers report.
“About 69% of the mortality disparity could in theory be reduced or eliminated if we just provided optimal, guideline-based care to
women at a similar rate as we do to men,” senior author Deepak L. Bhatt, MD, of Brigham and Women’s Hospital (Boston, MA), told
TCTMD. He pointed out that the analysis took into account that some patients might have a legitimate contraindication to an aspect of
recommended care.
Along with lead author Shanshan Li, MD, ScD, of the Harvard T.H. Chan School of Public Health (Boston, MA), Bhatt and colleagues used
data from the Get With the Guidelines-Coronary Artery Disease Registry to perform a cohort study of 49,358 patients ages 65 years and
older who were admitted to 366 US hospitals between 2003 and 2009. Reasons for admission spanned the spectrum from chronic stable angina and ischemic heart disease to unstable angina and acute MI.
The researchers sought to understand whether optimal quality of care—including aspirin within 24 hours and at hospital discharge,
beta-blocker at discharge, ACE inhibitor/ARB at discharge for patients with low ejection fraction, smoking cessation counseling, and
lipid-lowering medications—might serve as a mediator of outcomes. Their findings were published online earlier this week in Circulation: Cardiovascular Quality and Outcomes.
Women were less likely to receive optimal care than were men (OR 0.92; 95% CI 0.88-0.95). Among patients given suboptimal care,
women had higher 3-year mortality than did their male counterparts (OR 1.25; 95% CI 1.00-1.05). The interplay between sex, quality of
care, and mortality risk was significant (P for interaction = .04).
“Approximately 69% of the sex disparity may potentially be reduced by providing optimal quality of care to women,” the authors assert. Notably, the quality of care did not differ among racial/ethnic groups or geographic regions. While African-American patients were
one-third more likely than white patients to die within 3 years (OR 1.33; 95% 1.21-1.46), this disparity was not ameliorated for those
receiving optimal care.
Good News and Bad News
Acknowledging that the findings for women could be seen as “the glass is half full or half empty,” Bhatt said, “I actually interpret it as
good news because it means that whatever mortality gaps there are in women versus men, at least for coronary artery disease, a good
chunk of it can be reduced. . . . It would take effort, of course. It’s not an easy thing to always deliver optimal guideline-based care, but
it’s not as if it’s an unknown biological mechanism that has yet to be uncovered.”
That being said, he added, there could well be some biological differences that merit further study.
The persistent mortality risk seen for African-American patients “even if delivery of care is excellent,” Bhatt said, “is not such an optimistic message.”
Delivery of care does vary by race and by socioeconomic status, he noted. “But even if those [disparities in care] were magically eliminated, our study suggests that African-American patients would still have higher mortality. That is concerning, and that means there
are other factors. Not necessarily just fundamental biological factors; there could be other things that we couldn’t totally account for,
like access to healthcare or [a patient’s] socioeconomic status, but it is a bit more sobering message. It argues that there isn’t an as
apparent or easy a fix in African-Americans.
Source: Li S, Fonarow GC, Mukamal KJ, et al. Sex and race/ethnicity related disparities in care and outcomes after hospitalization for coronary artery
disease among older adults. Circ Cardiovasc Qual Outcomes. 2016;Epub ahead of print.
http://www.tctmd.com/show.aspx?id=134019
Articles Con’t
LAA Closures
Submitted by: Elaine Krieger, Chief Supervisor at Royal University Hospital of Saskatoon, SK.
Occlusion of the left atrial appendage (LAA) for patients with atrial fibrillation (AF) is intended to reduce the risk of
thromboembolic events. Among patients with non-valvular AF, the vast majority of thrombi is located within or involves the LAA. While drug therapy may help these patients, not all are candidates for anticoagulation.
Enter percutaneous LAA closure devices. Currently, the only Canadian licensed LAA Closure device is the WATCHMAN
(Boston Scientific). The device is recapturable and repositionable.
This nitinol based device is covered with polyethylene terephthalate (PTFE), and has 10 anchors to aid tissue engagement. With femoral vein access, it is deployed via a transseptal puncture under transesophageal and x-ray guidance. It
is generally a one hour procedure, and the patients go home the next day after a follow up transthoracic echo.
Because the WATCHMAN is permeable to blood, patients require conventional thromboembolic prophylaxis
with warfarin until endothelialization has completed at approximately 45 days post-implant. In addition, all patients are
treated with dual antiplatelet therapy of aspirin and clopidogrel daily for six months.
Saskatoon’s Royal University Hospital was the first Canadian site to place the licensed devices on January 21, 2016,
though a number have been placed through special access. Our team consists of an Interventional Cardiologist, Electrophysiologist, Anaesthetist, Echo cardiologist, cardiovascular technologists, Cath lab RN, medical radiation technologist,
and the WATCHMAN clinical specialist.
Chicken wing, windsock, and broccoli are all descriptions of LAA anatomy.
PFT Symposium 2015
Congratulations to Laura Seed for successfully organizing our First Annual Pulmonary Function Testing Symposium!
The PFT Symposium was a huge success. There were over 50 delegates in attendance, with all looking forward to next
year's symposium! Please stay tuned for more details. I would like to extend a big thank you to all the speakers: Dr.
Chung-Wai Chow, Angela Thomas, Andrea White-Markham and Patrick Burns and an extra special thanks to Dr. Allan
Coates as he has been a big supporter of the CACPT education forums.
Please find the powerpoint presentations from the symposium on our website.
Board of Directors
The Board of Directors consists of six volunteer active members of the Canadian Association of CardioPulmonary Technologists (CACPT). The CACPT Board of Directors represents the entire country and is divided into three regions: Pacific, Central and Atlantic. Each region typically has two members actively volunteering with the CACPT Board of Directors, therefore each region is represented. Each year, members
are encouraged to nominate fellow members to serve on the CACPT Board of Directors for a two-year
term, if elected. Every year there are three positions open to nominations, one from each of the three
regions.
President: Glenda Ryan
Health Sciences Center
Cardio-Pulmonary Investigation Unit
300 Prince Phillip Dr.
St. John´s, NF
A1B 3V6
E-mail: [email protected]
Education Chair: Laura Seed
The Hospital for Sick Children
Pulmonary Function Lab
555 University Avenue
Toronto, ON
M5G 1X8
E-mail: [email protected]
Vice-President: Laura Seed
The Hospital for Sick Children
Pulmonary Function Lab
555 University Avenue
Toronto, ON
M5G 1X8
E-mail: [email protected]
Treasurer: Carol Collins
PO BOX 848
Station "A"
Toronto, Ontario
M5W 1G3
E-mail: [email protected]
Public Relations Officer: VACANT
Secretary: Jamey Urquhart
QEII Health Sciences Centre
Pulmonary Function Lab
PO Box 900
Halifax, NS
B3H 3A7
E-mail: [email protected]
Membership: Elaine Krieger
Cardiac Catheterization Services
Royal University Hospital
Saskatoon, SK
E-mail:
[email protected]
Canadian Association of Cardiopulmonary Technologists
P.O. Box 848, Station “A”
Toronto, ON
Canada
M5W 1G3
Email: [email protected]
http://www.cacpt.ca